Our Research Insights
Can TMS help with dementia? The latest research in 2026
TMS is being studied for Alzheimer’s and mild cognitive impairment, with some encouraging results. An honest look at the brain targets, the treatment schedules, why age changes the dose, and what TMS can and cannot do. Estimated read time: about 11 minutes.
What is D-cycloserine and why do we use it in our One-Day Intensive?
What is D-cycloserine and why do we use it in our One-Day Intensive? If you’ve read about our One-Day Intensive, you’ve seen D-cycloserine (TMS 1-Day treatment suppliment) mentioned as part of the protocol. Most patients have never heard of it. The name sounds clinical. It sounds like a medication and the question of whether you’re being given an additional psychiatric drug during an already unfamiliar procedure is a reasonable thing to want answered clearly. Here’s the clear answer: D-cycloserine is not a psychiatric drug. It doesn’t alter your mood, your perception, or your cognition in any meaningful way at the
The THREE-D Trial – iTBS Non-Inferior to Standard rTMS for Depression (Blumberger et al. 2018)
The THREE-D Trial – iTBS Non-Inferior to Standard rTMS for Depression (Blumberger et al. 2018) What this study was Who was studied What the protocol involved What the results showed What it means and what it doesn’t Why this study matters for patients What this study was The THREE-D trial is the largest randomized controlled trial comparing intermittent theta burst stimulation to standard high-frequency rTMS for major depressive disorder. It was a non-inferiority trial, meaning its primary question was not whether iTBS was better than rTMS, but whether it was at least as good. It was conducted across multiple Canadian
Ready to learn if TMS is right for you?
A brief conversation is all it takes. No pressure, no commitment – just clarity.